MMRF Research Roundtables encourage the sharing of ideas and knowledge, and build a team approach to finding a cure in cutting-edge areas of research. MMRF Roundtables bring together world leaders in academic research, the NCI, and the pharmaceutical industry. MMRF Roundtables are closed door, invite only (limited to 25 participants), interactive sessions whereby everyone in attendance presents their unpublished work. Meeting abstract books are disseminated to participants and a meeting summary may be submitted to peer-reviewed journals.
Read Development of Effective New Treatments for Myeloma, the resulting publication from the February 2004 Roundtable featured in the Journal of Clinical Oncology.
Research Roundtables
2007
-
Combination Strategies in the Treatment of Multiple Myeloma Research Roundtable
2005
-
Validating Compounds for Multiple Myeloma
-
A Strategic Framework for Novel Drug Development in Multiple Myeloma
-
Therapeutic Targets Research Roundtable
2004
-
Establishing a Framework for Conducting Intergroup Clinical Trials in Myeloma
-
Novel Targeted Therapies for the Treatment of Multiple Myeloma
-
Novel Targeted Therapies for the Treatment of Multiple Myeloma
2003
-
Novel Targeted Therapeutics for the Treatment of Multiple Myeloma
-
Molecular Genetics of Multiple Myeloma
2002
-
The Development of Novel Targeted Therapeutics for the Treatment of Multiple Myeloma
-
Advances in Plasma Cell Formation and Tumorigenesis Roundtable